Company QuidelOrtho Corporation

Equities

QDEL

US2197981051

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 21:00:00 18/07/2024 BST 5-day change 1st Jan Change
33.2 USD -4.73% Intraday chart for QuidelOrtho Corporation +5.46% -54.95%

Business Summary

QuidelOrtho Corporation is engaged in vitro diagnostics, developing and manufacturing intelligent solutions. The Company sells its products directly to end users through a direct sales force and through a network of distributors, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, other point-of-care (POC) settings, blood banks and donor centers, as well as for individual, non-professional, over the counter (OTC) use. The Company provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Connect, Ortho Plus, Ortho Vision, QuickVue, Quidel, QuidelOrtho, QVue, Savanna, Sofia, Solana, Thyretain, Triage, Virena, Vitros among others. It provides support for its customers across more than 130 countries and territories.

Number of employees: 7,100

Managers

Managers TitleAgeSince
Director of Finance/CFO 57 -
Chief Tech/Sci/R&D Officer 65 -
Chief Administrative Officer - 30/04/22
Chief Operating Officer 55 30/06/05
Chief Tech/Sci/R&D Officer 67 -
Corporate Officer/Principal 54 30/04/22
General Counsel - 30/11/20

Members of the board

Members of the board TitleAgeSince
Director/Board Member 71 31/12/13
Chairman 70 -
Director/Board Member 80 31/12/92
Director/Board Member 58 31/07/20
Director/Board Member 51 31/12/17
Director/Board Member 66 31/12/17
Director/Board Member 69 31/12/21
Director/Board Member 41 31/12/21
Director/Board Member 62 31/12/20
Director/Board Member 55 11-27

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 66,971,816 54,971,807 ( 82.08 %) 0 82.08 %

Shareholders

NameEquities%Valuation
The Carlyle Group LP (Global Private Equity)
16.27 %
10,894,562 16.27 % 362 M $
T. Rowe Price Investment Management, Inc.
14.48 %
9,699,228 14.48 % 322 M $
Vanguard Fiduciary Trust Co.
7.285 %
4,879,143 7.285 % 162 M $
BlackRock Advisors LLC
6.873 %
4,603,251 6.873 % 153 M $
Rubric Capital Management LP
3.584 %
2,400,000 3.584 % 80 M $
ArrowMark Colorado Holdings LLC
3.505 %
2,347,227 3.505 % 78 M $
1,583,678 2.365 % 53 M $
DFA Australia Ltd.
2.043 %
1,368,081 2.043 % 45 M $
JPMorgan Investment Management, Inc.
2.041 %
1,367,152 2.041 % 45 M $
Maverick Capital Ltd.
2.025 %
1,356,251 2.025 % 45 M $

Company contact information

QuidelOrtho Corp.

9975 Summers Ridge Road

92121, San Diego

+858 552 1100

http://www.quidelortho.com
address QuidelOrtho Corporation(QDEL)

Group companies

NameCategory and Sector
Medical Specialties
Medical Specialties
  1. Stock Market
  2. Equities
  3. QDEL Stock
  4. Company QuidelOrtho Corporation